OBITUARY- Riccardo Saccardi (20th April 1956–19th February 2024) - Top-Institutions - MDSpire

OBITUARY- Riccardo Saccardi (20th April 1956–19th February 2024)

  • By

  • Andrea Bacigalupo

  • Francesca Bonifazi

  • Fabio Ciceri

  • Eliane Gluckman

  • Raffaella Greco

  • Chiara Nozzoli

  • Letizia Lombardini

  • Massimo Martino

  • Alessandro Rambaldi

  • Vanderson Rocha

  • Annalisa Ruggeri

  • John Snowden

  • Anna Sureda

  • May 1, 2024

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Careggi University Hospital
    Careggi University Hospital

    Florence, Tuscany

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Autoimmune Diseases
    • Cellular Therapies

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Immunotherapy

  • #3

    Hôpital Saint-Louis
    Hôpital Saint-Louis

    Paris, Île-de-France

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Autoimmune Diseases

  • #4

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    Barcelona, Catalonia

    Key Differentiators

    • Stem Cell Transplantation
    • Autoimmune Diseases
    • Cellular Therapy Standards

Original Source(s)

OBITUARY- Riccardo Saccardi (20th April 1956–19th February 2024)

  • by Andrea Bacigalupo, Francesca Bonifazi, Fabio Ciceri, Eliane Gluckman, Raffaella Greco, Chiara Nozzoli, Letizia Lombardini, Massimo Martino, Alessandro Rambaldi, Vanderson Rocha, Annalisa Ruggeri, John Snowden, Anna Sureda

  • May 1, 2024

Related Content

CAR T cells and T cell engagers for autoimmunity—lessons from hematology

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

ATG and other serotherapy in conditioning regimens for autologous HSCT in autoimmune diseases: a survey on behalf of the EBMT Autoimmune Diseases Working Party (ADWP)